Translational research of novel hormones: Lessons from animal models and rare human diseases for common human diseases

Journal of Molecular Medicine

Volumn 87, Issue 10, 2009, Pages 1029-1039

  Nakao, Kazuwa ^a   Yasoda, Akihiro ^a   Ebihara, Ken ^a   Hosoda, Kiminori ^a   Mukoyama, Masashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Animal models; Genetically engineered mice; Leptin; Natriuretic peptide family (ANP, BNP, CNP); Translational research

Indexed keywords

ADIPOCYTOKINE; ANTIDIABETIC AGENT; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; GUANYLATE CYCLASE; INSULIN; LEPTIN; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C;

ACHONDROPLASIA; ACUTE PANCREATITIS; ADIPOSE TISSUE; ADJUVANT THERAPY; ALBUMINURIA; BONE DYSPLASIA; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CONTINUOUS INFUSION; CROSS BREEDING; DIABETES MELLITUS; DRUG WITHDRAWAL; ENDOCRINE CELL; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; FATTY LIVER; GENE DELETION; GENE OVEREXPRESSION; GENETIC DISORDER; GENETIC ENGINEERING; HORMONE ACTION; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPODYSTROPHY; MESENCHYMAL STEM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN FUNCTION; PROTEIN ISOLATION; RARE DISEASE; REVIEW; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HORMONES; HUMANS; LEPTIN; LIPODYSTROPHY; MICE; MICE, TRANSGENIC; NATRIURETIC PEPTIDES; TRANSLATIONAL RESEARCH;

EID: 70349567646     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0515-7     Document Type: Review

References (126)

1. K Okamoto K Aoki 1963 Development of a strain of spontaneously hypertensive rats Jpn Circ J 27 282 293 13939773 1:STN:280:DyaF387jtFCmsw%3D%3D
2. AM Ingalls MM Dickie GD Snell 1950 Obese, a new mutation in the house mouse J Heredity 41 317 318 1:STN:280:DyaG3M%2FlsVSrtQ%3D%3D
3. K Nakao Y Ogawa S Suga H Imura 1992 Molecular biology and biochemistry of the natriuretic peptide system. I: natriuretic peptides J Hypertens 10 907 912 1328371 1:CAS:528:DyaK3sXhs1Wjtbg%3D
4. K Nakao Y Ogawa S Suga H Imura 1992 Molecular biology and biochemistry of the natriuretic peptide system. II: natriuretic peptide receptors J Hypertens 10 1111 1114 1334991 1:CAS:528:DyaK3sXhtl2qt78%3D
5. S Suga K Nakao K Hosoda M Mukoyama Y Ogawa G Shirakami H Arai Y Saito Y Kambayashi K Inouye, et al. 1992 Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide Endocrinology 130 229 239 1309330 1:CAS:528: DyaK38XhtVSjtbk%3D
6. A Sugawara K Nakao N Morii T Yamada H Itoh S Shiono Y Saito M Mukoyama H Arai K Nishimura, et al. 1988 Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP J Clin Invest 81 1962 1970 2968368 1:STN:280:DyaL1c3lslClug%3D%3D
7. Y Saito K Nakao H Arai K Nishimura K Okumura K Obata G Takemura H Fujiwara A Sugawara T Yamada, et al. 1989 Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart J Clin Invest 83 298 305 2521342 1:STN:280:DyaL1M%2FptlCgsQ%3D%3D
8. M Mukoyama K Nakao Y Saito Y Ogawa K Hosoda S Suga G Shirakami M Jougasaki H Imura 1990 Human brain natriuretic peptide, a novel cardiac hormone Lancet 335 801 802 1969551 1:STN:280:DyaK3c3gsFeksA%3D%3D (Pubitemid 20106739)
9. M Mukoyama K Nakao Y Saito Y Ogawa K Hosoda S Suga G Shirakami M Jougasaki H Imura 1990 Increased human brain natriuretic peptide in congestive heart failure N Engl J Med 323 757 758 2143809 1:STN:280:DyaK3czls1Sqsw%3D%3D (Pubitemid 20288962)
10. M Mukoyama K Nakao K Hosoda S Suga Y Saito Y Ogawa G Shirakami M Jougasaki K Obata H Yasue, et al. 1991 Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide J Clin Invest 87 1402 1412 1849149 1:CAS:528:DyaK3MXitVSntr0%3D
11. E Morita H Yasue M Yoshimura H Ogawa M Jougasaki T Matsumura M Mukoyama K Nakao 1993 Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction Circulation 88 82 91 8319360 1:STN:280:DyaK3szgs1ygtQ%3D%3D (Pubitemid 23195436)
12. R Kawakami Y Saito I Kishimoto M Harada K Kuwahara N Takahashi Y Nakagawa M Nakanishi K Tanimoto S Usami, et al. 2004 Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction Circulation 110 3306 3312 15545516 1:CAS:528:DC%2BD2cXpsl2juro%3D
13. H Arai K Nakao Y Saito N Morii A Sugawara T Yamada H Itoh S Shiono M Mukoyama H Ohkubo, et al. 1988 Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone Circ Res 62 926 930 2966015 1:CAS:528:DyaL1cXktVCksrk%3D (Pubitemid 18126058)
14. H Yasue M Yoshimura H Sumida K Kikuta K Kugiyama M Jougasaki H Ogawa K Okumura M Mukoyama K Nakao 1994 Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 195 203 8025996 1:CAS:528:DyaK2cXmtVaitbw%3D
15. A Sugawara K Nakao M Sakamoto N Morii T Yamada H Itoh S Shiono H Imura 1985 Plasma concentration of atrial natriuretic polypeptide in essential hypertension Lancet 2 1426 1427 2867419 1:STN:280:DyaL28%2FptFWntQ%3D%3D
16. H Itoh K Nakao M Mukoyama T Yamada K Hosoda G Shirakami N Morii A Sugawara Y Saito S Shiono, et al. 1989 Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats J Clin Invest 84 145 154 2544622 1:CAS:528:DyaL1MXkslGks78%3D
17. Y Ogawa K Nakao M Mukoyama K Hosoda G Shirakami H Arai Y Saito S Suga M Jougasaki H Imura 1991 Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide Circ Res 69 491 500 1830518 1:CAS:528:DyaK3MXlvF2mtLw%3D
18. Y Saito K Nakao K Nishimura A Sugawara K Okumura K Obata R Sonoda T Ban H Yasue H Imura 1987 Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function Circulation 76 115 124 2954723 1:STN:280:DyaL2s3ksVOksw%3D%3D
19. M Yoshimura H Yasue E Morita N Sakaino M Jougasaki M Kurose M Mukoyama Y Saito K Nakao H Imura 1991 Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure Circulation 84 1581 1588 1914098 1:STN:280:DyaK38%2Fgs1SmtQ%3D%3D
20. T Sudoh N Minamino K Kangawa H Matsuo 1990 C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain Biochem Biophys Res Commun 168 863 870 2139780 1:CAS:528:DyaK3cXktFygtbw%3D (Pubitemid 20164622)
21. Y Komatsu K Nakao S Suga Y Ogawa M Mukoyama H Arai G Shirakami K Hosoda O Nakagawa N Hama, et al. 1991 C-type natriuretic peptide (CNP) in rats and humans Endocrinology 129 1104 1106 1855454 1:CAS:528:DyaK3MXmt1Clsbg%3D
22. S Suga K Nakao H Itoh Y Komatsu Y Ogawa N Hama H Imura 1992 Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system" J Clin Invest 90 1145 1149 1522222 1:CAS:528:DyaK38XlvVGmu70%3D
23. S Suga H Itoh Y Komatsu Y Ogawa N Hama T Yoshimasa K Nakao 1993 Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells Endocrinology 133 3038 3041 8243333 1:CAS:528: DyaK2cXks1KisQ%3D%3D
24. K Doi H Itoh Y Komatsu T Igaki TH Chun K Takaya J Yamashita M Inoue T Yoshimasa K Nakao 1996 Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion Hypertension 27 811 815 8613245 1:CAS:528:DyaK28Xit1Gitr8%3D
25. A Kubo Y Isumi Y Ishizaka Y Tomoda K Kangawa K Dohi H Matsuo N Minamino 2001 C-type natriuretic peptide is synthesized and secreted from leukemia cell lines, peripheral blood cells, and peritoneal macrophages Exp Hematol 29 609 615 11376874 1:CAS:528:DC%2BD3MXjslCit7g%3D
26. Y Komatsu K Nakao H Itoh S Suga Y Ogawa H Imura 1992 Vascular natriuretic peptide Lancet 340 622 1355208 1:STN:280:DyaK38zot1eguw%3D%3D
27. N Hama H Itoh G Shirakami S Suga Y Komatsu T Yoshimasa I Tanaka K Mori K Nakao 1994 Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients Biochem Biophys Res Commun 198 1177 1182 8117275 1:CAS:528:DyaK2cXhvVylsL4%3D
28. Y Komatsu H Itoh S Suga Y Ogawa N Hama I Kishimoto O Nakagawa T Igaki K Doi T Yoshimasa, et al. 1996 Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition Circ Res 78 606 614 8635218 1:CAS:528:DyaK28XhvVynu74%3D
29. N Morii K Nakao A Sugawara M Sakamoto M Suda M Shimokura Y Kiso M Kihara Y Yamori H Imura 1985 Occurrence of atrial natriuretic polypeptide in brain Biochem Biophys Res Commun 127 413 419 3156596 1:CAS:528:DyaL2MXhsVertb4%3D (Pubitemid 16217448)
30. G Katsuura M Nakamura K Inouye M Kono K Nakao H Imura 1986 Regulatory role of atrial natriuretic polypeptide in water drinking in rats Eur J Pharmacol 121 285 287 2938978 1:CAS:528:DyaL28XhsVart7k%3D (Pubitemid 16117172)
31. T Yamada K Nakao N Morii H Itoh S Shiono M Sakamoto A Sugawara Y Saito H Ohno A Kanai, et al. 1986 Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats Eur J Pharmacol 125 453 456 2942414 1:CAS:528:DyaL28XkslegtL4%3D (Pubitemid 16037758)
32. G Shirakami K Nakao T Yamada H Itoh K Mori K Kangawa N Minamino H Matsuo H Imura 1988 Inhibitory effect of brain natriuretic peptide on central angiotensin II-stimulated pressor response in conscious rats Neurosci Lett 91 77 83 2971901 1:CAS:528:DyaL1cXlt1eit7o%3D
33. G Shirakami H Itoh S Suga Y Komatsu N Hama K Mori K Nakao 1993 Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats Neurosci Lett 159 25 28 8264972 1:CAS:528:DyaK3sXms1ens78%3D
34. M Kawata K Nakao N Morii Y Kiso H Yamashita H Imura Y Sano 1985 Atrial natriuretic polypeptide: topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry Neuroscience 16 521 546 2936980 1:STN:280:DyaL287kslegsw%3D%3D
35. H Itoh K Nakao G Katsuura N Morii S Shiono M Sakamoto A Sugawara T Yamada Y Saito A Matsushita, et al. 1986 Centrally infused atrial natriuretic polypeptide attenuates exaggerated salt appetite in spontaneously hypertensive rats Circ Res 59 342 347 2945672 1:CAS:528:DyaL2sXhtlKntg%3D%3D
36. H Itoh K Nakao N Morii T Yamada S Shiono M Sakamoto A Sugawara Y Saito G Katsuura T Shiomi, et al. 1986 Central action of atrial natriuretic polypeptide on blood pressure in conscious rats Brain Res Bull 16 745 749 2943361 1:CAS:528:DyaL28XkvFajt7s%3D
37. N Morii K Nakao H Itoh S Shiono T Yamada A Sugawara Y Saito M Mukoyama H Arai M Sakamoto, et al. 1987 Atrial natriuretic polypeptide in spinal cord and autonomic ganglia Biochem Biophys Res Commun 145 196 203 2954548 1:CAS:528:DyaL2sXktFyms7s%3D
38. H Itoh K Nakao T Yamada N Morii S Shiono A Sugawara Y Saito M Mukoyama H Arai H Imura 1988 Brain renin-angiotensin. Central control of secretion of atrial natriuretic factor from the heart Hypertension 11 I57 61 2964405 1:CAS:528:DyaL1cXhsVCisLs%3D
39. M Harada H Itoh O Nakagawa Y Ogawa Y Miyamoto K Kuwahara E Ogawa T Igaki J Yamashita I Masuda, et al. 1997 Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes Circulation 96 3737 3744 9396478 1:CAS:528:DyaK2sXnslyitb4%3D
40. K Yamahara H Itoh TH Chun Y Ogawa J Yamashita N Sawada Y Fukunaga M Sone T Yurugi-Kobayashi K Miyashita, et al. 2003 Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration Proc Natl Acad Sci U S A 100 3404 3409 12621153 1:CAS:528:DC%2BD3sXisVCnur4%3D
41. ME Steinhelper KL Cochrane LJ Field 1990 Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes Hypertension 16 301 307 2144261 1:CAS:528:DyaK3MXhsl2htr4%3D
42. SW John JH Krege PM Oliver JR Hagaman JB Hodgin SC Pang TG Flynn O Smithies 1995 Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension Science 267 679 681 7839143 1:CAS:528:DyaK2MXjsFGltL8%3D
43. Y Ogawa H Itoh N Tamura S Suga T Yoshimasa M Uehira S Matsuda S Shiono H Nishimoto K Nakao 1994 Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene J Clin Invest 93 1911 1921 8182124 1:CAS:528:DyaK2cXksFWjurY%3D
44. N Tamura Y Ogawa H Chusho K Nakamura K Nakao M Suda M Kasahara R Hashimoto G Katsuura M Mukoyama, et al. 2000 Cardiac fibrosis in mice lacking brain natriuretic peptide Proc Natl Acad Sci U S A 97 4239 4244 10737768 1:CAS:528:DC%2BD3cXislSgu7g%3D
45. MJ Lopez SK Wong I Kishimoto S Dubois V Mach J Friesen DL Garbers A Beuve 1995 Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide Nature 378 65 68 7477288 1:CAS:528:DyaK2MXptVyqsr0%3D
46. T Suganami M Mukoyama A Sugawara K Mori T Nagae M Kasahara K Yahata H Makino Y Fujinaga Y Ogawa, et al. 2001 Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury J Am Soc Nephrol 12 2652 2663 11729234 1:CAS:528:DC%2BD38XktF2r
47. M Kasahara M Mukoyama A Sugawara H Makino T Suganami Y Ogawa M Nakagawa K Yahata M Goto R Ishibashi, et al. 2000 Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation J Am Soc Nephrol 11 1691 1701 10966494 1:CAS:528:DC%2BD3cXntFKru7o%3D
48. H Makino M Mukoyama K Mori T Suganami M Kasahara K Yahata T Nagae H Yokoi K Sawai Y Ogawa, et al. 2006 Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice Diabetologia 49 2514 2524 16917760 1:CAS:528:DC%2BD28XptF2kur0%3D
49. M Suda Y Ogawa K Tanaka N Tamura A Yasoda T Takigawa M Uehira H Nishimoto H Itoh Y Saito, et al. 1998 Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide Proc Natl Acad Sci U S A 95 2337 2342 9482886 1:CAS:528:DyaK1cXhsleitL4%3D
50. H Chusho Y Ogawa N Tamura M Suda A Yasoda T Miyazawa I Kishimoto Y Komatsu H Itoh K Tanaka, et al. 2000 Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways Endocrinology 141 3807 3813 11014237 1:CAS:528:DC%2BD3cXmvVGmtr4%3D
51. PM Oliver JE Fox R Kim HA Rockman HS Kim RL Reddick KN Pandey SL Milgram O Smithies N Maeda 1997 Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A Proc Natl Acad Sci U S A 94 14730 14735 9405681 1:CAS:528:DyaK1cXis1Oktg%3D%3D
52. JW Knowles G Esposito L Mao JR Hagaman JE Fox O Smithies HA Rockman N Maeda 2001 Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice J Clin Invest 107 975 984 11306601 1:CAS:528:DC%2BD3MXivVKjtL8%3D
53. I Kishimoto K Rossi DL Garbers 2001 A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy Proc Natl Acad Sci U S A 98 2703 2706 11226303 1:CAS:528:DC%2BD3MXhslKmtrs%3D
54. R Holtwick M Gotthardt B Skryabin M Steinmetz R Potthast B Zetsche RE Hammer J Herz M Kuhn 2002 Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure Proc Natl Acad Sci U S A 99 7142 7147 11997476 1:CAS:528:DC%2BD38XjvFCqu74%3D
55. R Holtwick M van Eickels BV Skryabin HA Baba A Bubikat F Begrow MD Schneider DL Garbers M Kuhn 2003 Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A J Clin Invest 111 1399 1407 12727932 1:CAS:528:DC%2BD3sXjsFCrs7w%3D
56. K Sabrane MN Kruse L Fabritz B Zetsche D Mitko BV Skryabin M Zwiener HA Baba M Yanagisawa M Kuhn 2005 Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide J Clin Invest 115 1666 1674 15931395 1:CAS:528:DC%2BD2MXkvF2ls74%3D
57. N Tamura Y Ogawa A Yasoda H Itoh Y Saito K Nakao 1996 Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes J Mol Cell Cardiol 28 1811 1815 8877790 1:CAS:528:DyaK28XlsF2jtbw%3D
58. K Kuwahara Y Saito E Ogawa N Takahashi Y Nakagawa Y Naruse M Harada I Hamanaka T Izumi Y Miyamoto, et al. 2001 The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes Mol Cell Biol 21 2085 2097 11238943 1:CAS:528:DC%2BD3MXjslWhtLo%3D
59. K Kuwahara Y Saito M Takano Y Arai S Yasuno Y Nakagawa N Takahashi Y Adachi G Takemura M Horie, et al. 2003 NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function EMBO J 22 6310 6321 14633990 1:CAS:528:DC%2BD3sXpvVemsbw%3D
60. H Chusho N Tamura Y Ogawa A Yasoda M Suda T Miyazawa K Nakamura K Nakao T Kurihara Y Komatsu, et al. 2001 Dwarfism and early death in mice lacking C-type natriuretic peptide Proc Natl Acad Sci U S A 98 4016 4021 11259675 1:CAS:528:DC%2BD3MXis1Khtr8%3D
61. HM Kronenberg 2003 Developmental regulation of the growth plate Nature 423 332 336 12748651 1:CAS:528:DC%2BD3sXjs1ynu7s%3D
62. A Yasoda Y Komatsu H Chusho T Miyazawa A Ozasa M Miura T Kurihara T Rogi S Tanaka M Suda, et al. 2004 Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway Nat Med 10 80 86 14702637 1:CAS:528:DC%2BD2cXlsFCq
63. N Tamura LK Doolittle RE Hammer JM Shelton JA Richardson DL Garbers 2004 Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs Proc Natl Acad Sci U S A 101 17300 17305 15572448 1:CAS:528:DC%2BD2cXhtFansr%2FM
64. TH Langenickel J Buttgereit I Pagel-Langenickel M Lindner J Monti K Beuerlein N Al-Saadi R Plehm E Popova J Tank, et al. 2006 Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B Proc Natl Acad Sci U S A 103 4735 4740 16537417 1:CAS:528:DC%2BD28Xjtl2nsr8%3D
65. R Feil SM Lohmann H de Jonge U Walter F Hofmann 2003 Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice Circ Res 93 907 916 14615494 1:CAS:528:DC%2BD3sXoslykur4%3D
66. A Pfeifer A Aszodi U Seidler P Ruth F Hofmann R Fassler 1996 Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II Science 274 2082 2086 8953039 1:CAS:528:DyaK2sXjtFCk
67. T Miyazawa Y Ogawa H Chusho A Yasoda N Tamura Y Komatsu A Pfeifer F Hofmann K Nakao 2002 Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification Endocrinology 143 3604 3610 12193576 1:CAS:528:DC%2BD38XmsVSgu7g%3D
68. T Tsuji T Kunieda 2005 A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse J Biol Chem 280 14288 14292 15722353 1:CAS:528:DC%2BD2MXivV2rsbc%3D
69. C Sogawa T Tsuji Y Shinkai K Katayama T Kunieda 2007 Short-limbed dwarfism: slw is a new allele of Npr2 causing chondrodysplasia J Heredity 98 575 580 1:CAS:528:DC%2BD2sXhtFWiurbJ
70. Y Jiao J Yan F Jiao H Yang LR Donahue X Li BA Roe J Stuart W Gu 2007 A single nucleotide mutation in Nppc is associated with a long bone abnormality in lbab mice BMC Genet 8 16 17439653
71. T Tsuji E Kondo A Yasoda M Inamoto C Kiyosu K Nakao T Kunieda 2008 Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification Biochem Biophys Res Commun 376 186 190 18775416 1:CAS:528:DC%2BD1cXhtFyqt7bO
72. A Superti-Furga L Bonafe DL Rimoin 2001 Molecular-pathogenetic classification of genetic disorders of the skeleton Am J Med Genet 106 282 293 11891680 1:STN:280:DC%2BD387lvVSitw%3D%3D
73. F Rousseau J Bonaventure L Legeai-Mallet A Pelet JM Rozet P Maroteaux M Le Merrer A Munnich 1994 Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia Nature 371 252 254 8078586 1:CAS:528: DyaK2cXmt1Oqsbc%3D
74. R Cattaneo A Villa M Catagni L Tentori 1988 Limb lengthening in achondroplasia by Ilizarov's method Int Orthop 12 173 179 3182120 1:STN:280:DyaL1M%2Fjt1Oitg%3D%3D
75. A Yasoda H Kitamura T Fujii E Kondo N Murao M Miura N Kanamoto Y Komatsu H Arai K Nakao 2009 Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias Endocrinology 150 3138 3144 19282381 1:CAS:528:DC%2BD1MXotlCrsrc%3D
76. T Igaki H Itoh SI Suga N Hama Y Ogawa Y Komatsu J Yamashita K Doi TH Chun K Nakao 1998 Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide Hypertens Res 21 7 13 9582102 1:CAS:528:DyaK1cXisFyktL4%3D
77. CF Bartels H Bukulmez P Padayatti DK Rhee C van Ravenswaaij-Arts RM Pauli S Mundlos D Chitayat LY Shih LI Al-Gazali, et al. 2004 Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux Am J Hum Genet 75 27 34 15146390 1:CAS:528:DC%2BD2cXltFClsrs%3D
78. Y Zhang R Proenca M Maffei M Barone L Leopold JM Friedman 1994 Positional cloning of the mouse obese gene and its human homologue Nature 372 425 432 7984236 1:CAS:528:DyaK2MXisVGqsbs%3D
79. JM Friedman JL Halaas 1998 Leptin and the regulation of body weight in mammals Nature 395 763 770 9796811 1:CAS:528:DyaK1cXmvFOmsL0%3D
80. MA Pelleymounter MJ Cullen MB Baker R Hecht D Winters T Boone F Collins 1995 Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 540 543 7624776 1:CAS:528:DyaK2MXntF2ktr4%3D
81. JL Halaas KS Gajiwala M Maffei SL Cohen BT Chait D Rabinowitz RL Lallone SK Burley JM Friedman 1995 Weight-reducing effects of the plasma protein encoded by the obese gene Science 269 543 546 7624777 1:CAS:528:DyaK2MXntF2ktr8%3D
82. LA Campfield FJ Smith Y Guisez R Devos P Burn 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks Science 269 546 549 7624778 1:CAS:528:DyaK2MXntF2ktrw%3D
83. N Satoh Y Ogawa G Katsuura Y Numata T Tsuji M Hayase K Ebihara H Masuzaki K Hosoda Y Yoshimasa, et al. 1999 Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion Diabetes 48 1787 1793 10480609 1:CAS:528:DyaK1MXmtVaitLg%3D
84. LA Tartaglia M Dembski X Weng N Deng J Culpepper R Devos GJ Richards LA Campfield FT Clark J Deeds, et al. 1995 Identification and expression cloning of a leptin receptor, OB-R Cell 83 1263 1271 8548812 1:CAS:528: DyaK28XhsVOmtg%3D%3D
85. Y Ogawa H Masuzaki N Isse T Okazaki K Mori M Shigemoto N Satoh N Tamura K Hosoda Y Yoshimasa, et al. 1995 Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats J Clin Invest 96 1647 1652 7657834 1:CAS:528:DyaK2MXnvVGqu7o%3D
86. K Takaya Y Ogawa J Hiraoka K Hosoda Y Yamori K Nakao RJ Koletsky 1996 Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat Nat Genet 14 130 131 8841178 1:CAS:528:DyaK28XmtVKnt7w%3D
87. RC Frederich A Hamann S Anderson B Lollmann BB Lowell JS Flier 1995 Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action Nat Med 1 1311 1314 7489415 1:CAS:528: DyaK2MXpslGhur8%3D
88. M Maffei J Halaas E Ravussin RE Pratley GH Lee Y Zhang H Fei S Kim R Lallone S Ranganathan, et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects Nat Med 1 1155 1161 7584987 1:CAS:528:DyaK2MXptFahs7s%3D
89. RV Considine MK Sinha ML Heiman A Kriauciunas TW Stephens MR Nyce JP Ohannesian CC Marco LJ McKee TL Bauer, et al. 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 334 292 295 8532024 1:STN:280:DyaK287jtlOnsw%3D%3D
90. N Isse Y Ogawa N Tamura H Masuzaki K Mori T Okazaki N Satoh M Shigemoto Y Yoshimasa S Nishi, et al. 1995 Structural organization and chromosomal assignment of the human obese gene J Biol Chem 270 27728 27733 7499240 1:CAS:528:DyaK2MXpsFShtL4%3D
91. N Satoh Y Ogawa G Katsuura T Tsuji H Masuzaki J Hiraoka T Okazaki M Tamaki M Hayase Y Yoshimasa, et al. 1997 Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats Endocrinology 138 947 954 9048594 1:CAS:528:DyaK2sXht1Okur8%3D
92. K Imagawa Y Numata G Katsuura I Sakaguchi A Morita S Kikuoka Y Matumoto T Tsuji M Tamaki K Sasakura, et al. 1998 Structure-function studies of human leptin J Biol Chem 273 35245 35249 9857064 1:CAS:528:DyaK1MXisFagug%3D%3D
93. JF Caro JW Kolaczynski MR Nyce JP Ohannesian I Opentanova WH Goldman RB Lynn PL Zhang MK Sinha RV Considine 1996 Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance Lancet 348 159 161 8684156 1:STN:280:DyaK283psFaqtQ%3D%3D
94. JL Halaas C Boozer J Blair-West N Fidahusein DA Denton JM Friedman 1997 Physiological response to long-term peripheral and central leptin infusion in lean and obese mice Proc Natl Acad Sci U S A 94 8878 8883 9238071 1:CAS:528:DyaK2sXltlWhtL4%3D
95. T Tanaka H Masuzaki S Yasue K Ebihara T Shiuchi T Ishii N Arai M Hirata H Yamamoto T Hayashi, et al. 2007 Central melanocortin signaling restores skeletal muscle AMP-activated protein kinase phosphorylation in mice fed a high-fat diet Cell Metab 5 395 402 17488641 1:CAS:528:DC%2BD2sXmt1ajsrw%3D
96. CT Montague IS Farooqi JP Whitehead MA Soos H Rau NJ Wareham CP Sewter JE Digby SN Mohammed JA Hurst, et al. 1997 Congenital leptin deficiency is associated with severe early-onset obesity in humans Nature 387 903 908 9202122 1:CAS:528:DyaK2sXkt1Grtbg%3D
97. A Strobel T Issad L Camoin M Ozata AD Strosberg 1998 A leptin missense mutation associated with hypogonadism and morbid obesity Nat Genet 18 213 215 9500540 1:CAS:528:DyaK1cXhtlKks7k%3D
98. S Yura Y Ogawa N Sagawa H Masuzaki H Itoh K Ebihara M Aizawa-Abe S Fujii K Nakao 2000 Accelerated puberty and late-onset hypothalamic hypogonadism in female transgenic skinny mice overexpressing leptin J Clin Invest 105 749 755 10727443 1:CAS:528:DC%2BD3cXhvFehsb4%3D
99. M Aizawa-Abe Y Ogawa H Masuzaki K Ebihara N Satoh H Iwai N Matsuoka T Hayashi K Hosoda G Inoue, et al. 2000 Pathophysiological role of leptin in obesity-related hypertension J Clin Invest 105 1243 1252 10791999 1:CAS:528:DC%2BD3cXivFKgtro%3D
100. F Elefteriou S Takeda K Ebihara J Magre N Patano CA Kim Y Ogawa X Liu SM Ware WJ Craigen, et al. 2004 Serum leptin level is a regulator of bone mass Proc Natl Acad Sci U S A 101 3258 3263 14978271 1:CAS:528:DC%2BD2cXitlWhurs%3D
101. T Suganami M Mukoyama K Mori H Yokoi M Koshikawa K Sawai S Hidaka K Ebihara T Tanaka A Sugawara, et al. 2005 Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy FASEB J 19 127 129 15496495 1:CAS:528:DC%2BD2MXitVGhtw%3D%3D
102. H Masuzaki Y Ogawa K Hosoda T Miyawaki I Hanaoka J Hiraoka A Yasuno H Nishimura Y Yoshimasa S Nishi, et al. 1997 Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome J Clin Endocrinol Metab 82 2542 2547 9253331 1:CAS:528: DyaK2sXltFGqsbo%3D
103. H Masuzaki Y Ogawa N Sagawa K Hosoda T Matsumoto H Mise H Nishimura Y Yoshimasa I Tanaka T Mori, et al. 1997 Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans Nat Med 3 1029 1033 9288733 1:CAS:528:DyaK2sXlvVyrtL0%3D
104. N Sagawa T Mori H Masuzaki Y Ogawa K Nakao 1997 Leptin production by hydatidiform mole Lancet 350 1518 1519 9388403 1:STN:280:DyaK1c%2FkvFOmtQ%3D%3D
105. Y Ogawa H Masuzaki K Hosoda M Aizawa-Abe J Suga M Suda K Ebihara H Iwai N Matsuoka N Satoh, et al. 1999 Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin Diabetes 48 1822 1829 10480614 1:CAS:528:DyaK1MXmtVaitb8%3D
106. H Masuzaki Y Ogawa N Isse N Satoh T Okazaki M Shigemoto K Mori N Tamura K Hosoda Y Yoshimasa, et al. 1995 Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue Diabetes 44 855 858 7789654 1:CAS:528:DyaK2MXms1Cms70%3D
107. E Ioffe B Moon E Connolly JM Friedman 1998 Abnormal regulation of the leptin gene in the pathogenesis of obesity Proc Natl Acad Sci U S A 95 11852 11857 9751754 1:CAS:528:DyaK1cXmsV2hsLk%3D
108. H Masuzaki Y Ogawa M Aizawa-Abe K Hosoda J Suga K Ebihara N Satoh H Iwai G Inoue H Nishimura, et al. 1999 Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes Diabetes 48 1615 1622 10426381 1:CAS:528:DyaK1MXkvVKmsro%3D
109. T Tanaka S Hidaka H Masuzaki S Yasue Y Minokoshi K Ebihara H Chusho Y Ogawa T Toyoda K Sato, et al. 2005 Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification Diabetes 54 2365 2374 16046303 1:CAS:528: DC%2BD2MXnt1yntrs%3D
110. S Kamohara R Burcelin JL Halaas JM Friedman MJ Charron 1997 Acute stimulation of glucose metabolism in mice by leptin treatment Nature 389 374 377 9311777 1:CAS:528:DyaK2sXmsVWqt7o%3D
111. L Liu GB Karkanias JC Morales M Hawkins N Barzilai J Wang L Rossetti 1998 Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes J Biol Chem 273 31160 31167 9813020 1:CAS:528:DyaK1cXns1egurw%3D
112. I Cusin KE Zakrzewska O Boss P Muzzin JP Giacobino D Ricquier B Jeanrenaud F Rohner-Jeanrenaud 1998 Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins Diabetes 47 1014 1019 9648822 1:CAS:528:DyaK1cXkt1ajt78%3D
113. Goldstein BJ (1994) Syndrome of extreme insulin resistance. In: Kahn CR, Weir GC (eds) Joslin's diabetes mellitus. Lea & Febiger, Philadelphia
114. F Andreelli H Hanaire-Broutin M Laville JP Tauber JP Riou C Thivolet 2000 Normal reproductive function in leptin-deficient patients with lipoatrophic diabetes J Clin Endocrinol Metab 85 715 719 10690881 1:CAS:528: DC%2BD3cXhtlyhu7s%3D
115. VC Pardini IM Victoria SM Rocha DG Andrade AM Rocha FB Pieroni G Milagres S Purisch G Velho 1998 Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatrophic diabetes J Clin Endocrinol Metab 83 503 508 9467565 1:CAS:528: DyaK1cXpvFaisA%3D%3D
116. J Moitra MM Mason M Olive D Krylov O Gavrilova B Marcus-Samuels L Feigenbaum E Lee T Aoyama M Eckhaus, et al. 1998 Life without white fat: a transgenic mouse Genes Dev 12 3168 3181 9784492 1:CAS:528:DyaK1cXnsVSnsL0%3D
117. I Shimomura RE Hammer JA Richardson S Ikemoto Y Bashmakov JL Goldstein MS Brown 1998 Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy Genes Dev 12 3182 3194 9784493 1:CAS:528:DyaK1cXnsVSnsLk%3D
118. K Ebihara Y Ogawa H Masuzaki M Shintani F Miyanaga M Aizawa-Abe T Hayashi K Hosoda G Inoue Y Yoshimasa, et al. 2001 Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes Diabetes 50 1440 1448 11375346 1:CAS:528:DC%2BD3MXkvFSgtro%3D
119. H Kobayashi Y Ogawa M Shintani K Ebihara M Shimodahira T Iwakura M Hino T Ishihara K Ikekubo H Kurahachi, et al. 2002 A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity Diabetes 51 243 246 11756348 1:CAS:528:DC%2BD38Xlt1egtg%3D%3D
120. C Vaisse K Clement E Durand S Hercberg B Guy-Grand P Froguel 2000 Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity J Clin Invest 106 253 262 10903341 1:CAS:528:DC%2BD3cXkvFWgsrY%3D
121. IS Farooqi GS Yeo JM Keogh S Aminian SA Jebb G Butler T Cheetham S O'Rahilly 2000 Dominant and recessive inheritance of morbid obesity associated
122. EA Oral V Simha E Ruiz A Andewelt A Premkumar P Snell AJ Wagner AM DePaoli ML Reitman SI Taylor, et al. 2002 Leptin-replacement therapy for lipodystrophy N Engl J Med 346 570 578 11856796 1:CAS:528:DC%2BD38XhsFKqu7c%3D
123. K Ebihara H Masuzaki K Nakao 2004 Long-term leptin-replacement therapy for lipoatrophic diabetes N Engl J Med 351 615 616 15295061 1:CAS:528: DC%2BD2cXmtF2qu74%3D
124. K Ebihara T Kusakabe M Hirata H Masuzaki F Miyanaga N Kobayashi T Tanaka H Chusho T Miyazawa T Hayashi, et al. 2007 Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy J Clin Endocrinol Metab 92 532 541 17118991 1:CAS:528:DC%2BD2sXitVaksb8%3D
125. F Miyanaga Y Ogawa K Ebihara S Hidaka T Tanaka S Hayashi H Masuzaki K Nakao 2003 Leptin as an adjunct of insulin therapy in insulin-deficient diabetes Diabetologia 46 1329 1337 12928770 1:CAS:528:DC%2BD3sXnvVCgur4%3D
126. T Kusakabe H Tanioka K Ebihara M Hirata L Miyamoto F Miyanaga H Hige D Aotani T Fujisawa H Masuzaki, et al. 2009 Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet Diabetologia 52 675 683 19169663 1:CAS:528:DC%2BD1MXisFSju7Y%3D